20/12/2021Published by Fondazione Gianni Bonadonna at 20/12/2021Categories Events UncategorizedElacestrant increases progression-free survival in patients with metastatic ER+/HER2- breast cancer
10/12/2021Published by Fondazione Gianni Bonadonna at 10/12/2021Categories Events UncategorizedTriple-negative breast cancer, the latest news from the Michelangelo Foundation research
07/12/2021Published by Fondazione Gianni Bonadonna at 07/12/2021Categories Events UncategorizedTriple-negative breast cancer, a ‘special’ imaging to predict immunotherapy response
06/12/2021Published by Fondazione Gianni Bonadonna at 06/12/2021Categories Events UncategorizedResearch from Michelangelo Foundation at San Antonio Breast Cancer Symposium 2021
29/11/2021Published by Fondazione Gianni Bonadonna at 29/11/2021Categories Events UncategorizedTriple-negative breast cancer, key immune cells for anti-PD-L1 response revealed
22/11/2021Published by Fondazione Gianni Bonadonna at 22/11/2021Categories Events UncategorizedBreast cancer METABRIC case series, a ‘goldmine’ of molecular data
16/11/2021Published by Fondazione Gianni Bonadonna at 16/11/2021Categories Events UncategorizedTriple negative breast cancer, new therapeutic options and future strategies
08/11/2021Published by Fondazione Gianni Bonadonna at 08/11/2021Categories Events UncategorizedImmunopeptidomics for the identification of noncanonical tumor antigens
01/11/2021Published by Fondazione Gianni Bonadonna at 01/11/2021Categories Events UncategorizedEarly-stage HER2+ breast cancer, HER2 heterogeneity predicts treatment resistance
